We're introducing a new look for GreyStone
The effects of Inherited Cardiac Conditions (ICC) on patients and their families can be enormous. Living with an inherited cardiac condition is distressing, but there are options for support available through genetic testing and counseling.
Cardiovascular genomics researchers have discovered numerous genetic variants associated with cardiac conditions. Studies have shown that most causative gene variants are rare and unique familial variants. These rare variants can be missed when small cardiac gene panels are used to diagnosis inherited heart diseases.
Greystone Lab’s comprehensive cardiovascular disease next-generation sequencing (NGS) panels provide broad coverage of cardiac genes with known disease associations. Unlike single-gene assays or small panels, which lead to time-consuming and expensive iterative testing, our expertly curated NGS panels assess multiple cardiac genes simultaneously.
Advances in genetic diagnostics are improving our understanding of a variety of inherited cardiovascular conditions—including cardiomyopathies, arrhythmic disorders, vascular disorders, and lipid disorders such as familial hypercholesterolemia.
Through cutting-edge genetic testing, we can help you determine a patient’s risk factors based on their DNA, so you can mitigate or even eliminate future consequences by taking steps now.
Unfortunately, most people who inherit cardiac conditions don’t know they are at risk, and many don’t suffer any symptoms until it’s too late.
Left undiagnosed and untreated, inherited cardiac conditions can lead to serious problems—such as coronary heart disease, heart attacks, sudden cardiac arrest, or even heart failure. Don’t wait until it’s too late. Get the insight you need to stay ahead of potentially fatal heart conditions.